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ABSTRACT 
 Protocadherins are a large, diverse family of neural cell adhesion proteins, but their 
functions are not understood. Mutations or in several protocadherins have been associated with 
neurological disorders. For example, Protocadherin19 (PCDH19) causes epilepsy in females 
with mental retardation (EFMR). In this X chromosome-linked disease, girls randomly express 
one good allele or one mutant allele per cell due to a phenomenon known as X-linked 
inactivation. This mosaic expression leads to the symptoms classified as EFMR, but the effects 
on cellular pathways for the disease are not known. In zebrafish, the loss of Pcdh19 leads to the 
loss of columnar organization in the developing optic tectum through the loss of adhesion and an 
increase in neuronal proliferation and differentiation. The literature shows that Pcdh19 interacts 
with Ryk, a noncanonical Wnt receptor involved in neurogenesis. Based on previous data and the 
literature, we hypothesize that Pcdh19 binds to the extracellular domain of Ryk to inhibit binding 
of the Wnt3 ligand, preventing the intracellular domain of Ryk from being cleaved and 
translocated to the nucleus where it would initiate pathways for neuronal proliferation. 
Immunohistochemistry and co-immunoprecipitation were attempted to show if Pcdh19 affects 
cleavage of the Ryk intracellular domain, its nuclear translocation, and subsequent Wnt 
signaling. Transgenic and Ryk-knockout fish are being developed to perform experiments in 
vivo.  
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PROBLEM STATEMENT 
 The developing embryo requires many processes to build a mature brain such as 
neurogenesis, neurulation, patterning of brain regions, neuronal or glial differentiation, neuronal 
migration, axon guidance, and synaptogenesis (Weiner and Jontes, 2013). All of these processes 
are controlled by a myriad of mechanisms, of which many work synchronously to accomplish a 
particular task. These neurodevelopmental events accumulate to produce functional neural 
circuits in the central and peripheral nervous systems that control cognition, emotion, behavior, 
and homeostasis. These processes must be tightly controlled to ensure that the neurons synapse 
on the correct partners. If any of these mechanisms are disrupted even slightly, the end result can 
be minor defects that may manifest themselves as small behavioral quirks, or they can be 
catastrophic morphologies that lead to miscarriages. However, not all disastrous breakdowns in 
neurodevelopment lead to a miscarriage. Other developmental malfunctions can cause moderate 
to severe cognitive and behavioral disabilities, but the child grows to adulthood due to the low 
lethality of the disorder. In fact, many neurological disorders can be categorized as 
neurodevelopmental issues, even if the disease doesn’t occur until later in life.  
 One neurological disorder that has become of interest in recent years is epilepsy in 
females with mental retardation (EFMR). EFMR is a neurodevelopmental disorder characterized 
by seizures and impaired intellectual functioning in females and starts presenting symptoms at a 
young age (Stevenson, 2012). Other psychiatric disorders such as obsessive and autistic 
behaviors have been linked to EFMR as well (Scheffer, et al., 2008). The symptoms of EFMR 
resemble Dravet Syndrome, a severe type of genetic epilepsy, and ranks second in prevalence of 
genetic epileptic disorders (Kwong, et al., 2007; Scheffer, 2012). Previous research has shown 
that heterozygous inheritance of a mutation in the Protocadherin-19 (PCDH19) allele leads to the 
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symptoms demonstrated in EFMR (Depienne et al., 2011). Strangely, homozygous inheritance of 
the correct or mutant allele does not lead to EFMR; only heterozygous inheritance of a mutation 
in PCDH19 leads to symptoms. Since PCDH19 resides on the female sex chromosome, the 
suspected cause for this unusual phenotype is X-chromosome inactivation (Duszyc, 2015). The 
stochastic expression of the normal allele in some cells and the mutant allele in others could 
disrupt the neural circuitry and create a form of miscommunication in the brain (Wu, et al., 
2014). However, the molecular mechanisms that would be affected as a result of X-chromosome 
inactivation are unknown. Defining the mechanism of EFMR would help doctors and researchers 
treat patients more effectively, could be extrapolated to understand other forms of epilepsy, and 
could be used to understand other neurological diseases as a result of X-chromosome 
inactivation. 
 Pcdh19 is a member of the protocadherin subfamily which is a part of the cadherin 
superfamily of adhesion molecules. Cadherins comprises approximately 100 members, with 
protocadherins consisting of at least 60 (Kim, et al., 2011; Redies, et al., 2012; Weiner and 
Jontes, 2013). Many of these proteins are expressed in the nervous system. Due to their diversity, 
similarity to classical cadherins, and different spatiotemporal expression, some investigators 
predict that protocadherins encode for particular circuits with stereotyped functions (Hertel, et 
al., 2008; Krishna, et al., 2011; Redies, et al., 2011; Vanhalst, et al., 2005). If this hypothesis is 
true, it could revolutionize our understanding and treatment of neurodevelopmental disorders. 
Therefore, study of protocadherins, specifically Pcdh19, outside of the context of disease is also 
critical to comprehending the development of the brain and how it forms neural circuits. 
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BACKGROUND 
 As mentioned earlier, protocadherins are a subfamily of the cadherin family of cell-
adhesion molecules. These proteins have been organized into one category based on the presence 
of repeated cadherin domains on the extracellular surface (Weiner and Jontes, 2013). However, 
their differing properties and sequence conservation has led to classifying cadherins in several 
subfamilies (Redies, et al., 2005). Protocadherins contain 6-7 cadherin repeats, expressed 
principally in the nervous system, and are organized into clustered and non-clustered 
protocadherins along with a couple of smaller groups (Kim, et al., 2011; Vanhalst, et al., 2005; 
Weiner and Jontes, 2013). Clustered protocadherins all appear near each other on the genome, 
whereas the non-clustered protocadherin genes are scattered (Kim, et al., 2011).  
 Within the group of non-clustered protocadherins, there are delta protocadherins. They 
also have highly conserved motifs in the cytoplasmic domain (Kim, et al., 2011). Pcdh19 falls 
under the domain of delta protocadherins. Generally, protocadherins exhibit weak, homophilic 
adhesion, unlike classical cadherins (Emond, et al., 2011; Kahr, et al., 2013). However, cis-
complexes between protocadherins and other molecules help to enhance protocadherin-mediated 
adhesion (Emond, et al., 2011; Weiner and Jontes, 2013). As described earlier, protocadherins 
are theorized to be involved in neural circuit formation. In fact, clustered protocadherins have 
been shown to be involved in dendrite arborization, axon guidance, synaptogenesis, and 
apoptosis (Weiner, 2013; Redies, 2012). Similarly, non-clustered protocadherins have been 
implicated in cell fate, axon guidance, cellular motility, synapse formation and stability (Kahr, 
2013; Redies, 2012). Additionally, classical cadherins can modulate the adhesive capability of 
delta protocadherins, further suggesting that non-clustered protocadherins are involved in circuit 
formation in the nervous system (Kim, 2011). 
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 Unlike some delta protocadherins, Pcdh19 has been directly connected to a neurological 
disease, which has been labeled EFMR (Camacho, et al., 2012). As mentioned earlier, this 
disease has puzzled researchers. Most X-linked mutations lead to symptoms in males because 
they only have one copy of genes which make them susceptible to both dominantly and 
recessively inherited diseases (Dibbens, et al., 2008). With only one X-chromosome, there isn’t 
the possibility for another healthy copy of the gene to compensate. Strangely, males that have or 
inherit a mutated and previously pathogenic form of the gene do not demonstrate symptoms 
(Depienne and LeGuern, 2012). Females are subject to X-linked dominant and recessive 
disorders. However, females that have mutations in both alleles of Pcdh19 do not show 
symptoms (Redies, et al., 2012; Harssel, et al., 2013). This genetic scenario would lead to the 
expression of dominant and recessive X-linked diseases, but this doesn’t actually occur. EFMR 
only occurs when a female has one correct copy and one mutated copy. The resulting hypothesis 
is that X-linked activation within among the neurons leads to scrambled communication, also 
known as cellular interference (Redies, et al. 2012; Harssel, et al., 2013; Dibbens, et al. 2008; 
Leonardi, et al., 2014). A couple of studies reported a few male patients with EFMR symptoms 
and mosaicism of de novo mutations in PCDH19 (Depienne, et al., 2009; Terracciano, et al., 
2016). These findings further support the hypothesis of X-linked inactivation leading to 
interference amongst neurons.  However, the pathogenic mechanism resulting from X-linked 
inactivation of a heterozygous female is unknown. Research suggests an inflammatory 
component due to the effectiveness of corticosteroids, but this has yet to be corroborated 
(Higurashi, et al., 2015). 
 As the name suggests, EFMR is primarily characterized by epilepsy and cognitive defects 
in females. Onset of seizures usually happens somewhere between 9 and 36 months with an 
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average onset at one year of age (Leonardi, et al., 2014; Higurashi, et al., 2013; Depienne and 
LeGuern, 2012). Seizures are often elicited by fevers (Specchio, et al., 2011). EEGs of EFMR 
patients are very similar to EEGs of patients diagnosed with Dravet syndrome. As a result, 
researchers often find EFMR patients among populations with Dravet-like symptoms but no 
mutations in the SCN1A gene (Kwong, et al., 2012; Scheffer, 2012). The characteristics of the 
seizures vary, but they are often described as clustered, focal seizures that can later develop into 
generalized seizures. Often accompanied by fearful screaming, EFMR patients demonstrate 
many types of seizures, such as tonic, clonic, tonic-clonic, myoclonic, absent, and atonic, which 
indicates that genetic screening is necessary for a definitive diagnosis (Higurashi, et al., 2013; 
Marini, et al., Marini, et al. 2010; 2011; Scheffer, et al., 2008; Specchio, et al. 2011). Early in 
life, infants and toddler experience 1-5 minute seizure up to 10 times a day. As they age, the 
severity and frequency of seizures decreases. Seizures disappear for some patients during 
adolescence, but they can persist throughout life for others (Higurashi, et al., 2013; Marini, et al., 
2010; Specchio, et al., 2011; Scheffer, et al., 2008). 
 Once the seizures begin, many patients begin to develop cognitive and behavioral defects. 
About 30% of patients retain normal intelligence, but the remaining 70% demonstrate mild to 
severe intellectual impairment (Dibbens, et al., 2008; Higurashi, et al., 2013; Marini, et al., 2012; 
Scheffer, et al., 2008). Several studies found patients with autistic, aggressive, and obsessive 
behaviors (Camacho, et al., 2012; Depienne and LeGuern, 2012; Scheffer, et al., 2008). Unlike 
the epileptic episodes, cognitive and psychiatric disabilities do not disappear with age. Females 
diagnosed with EFMR are linked by a mutation in the PCDH19 gene and onset of epilepsy as an 
infant. However, the variability in the type and severity of the seizures, intellectual impairment, 
and psychiatric disorders suggests two possibilities, of which one or both may be true. The first 
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scenario is that PCDH19 expression may be significant enough where disruptions lead to a 
maladaptive phenotype, but its expression may not be so ubiquitous that a normal phenotype 
cannot be recovered. Differential expression in distinct brain regions may prevent the onset of 
catastrophic symptoms such as those in other genetic disorders. The other scenario is that 
PCDH19 is part of a highly intricate system with many compensatory mechanisms that help 
mitigate symptoms and may even eliminate epileptic episodes. 
 However, most research into EFMR simply describes novel mutations in PCDH19, 
develops pedigrees, and characterizes the symptoms of disease (Camacho, et al., 2012; Leonardi, 
et al., 2014; Redies, et al., 2012; Harssel, et al., 2013; Dibbens, et al., 2008; Marini, et al., 2010; 
Higurashi, et al., 2013). The only results that have been any indicator of a molecular mechanism 
are that most pathogenic mutations occur in the extracellular domain and that corticosteroids 
alleviate epileptic seizures in EFMR patients (Harssel, et al., 2013; Higurashi, et al.; 2015; 
Depienne and LeGuern, 2012). Otherwise, no literature was found that describes a molecular 
mechanism for the disease. Our lab has turned its focus toward Pcdh19 to understand the roles of 
protocadherins in the nervous system.  
 Due to characteristics of embryonic and larval development, Danio rerio has become a 
well-established model for neural development (Rinkwitz, et al., 2011). Although zebrafish does 
not develop a neocortex analogous to mammals, many genes, proteins, and developmental 
pathways are conserved or very similar to those in mammalian pathways (Panula, et al., 2010). 
For example, the optic tectum, the primary visual processing center for zebrafish, develops in a 
fashion similar to the cortex, although it does not form the same cortical structure (Sumbre and 
de Polavieja, 2014). Progenitors in the neural epithelium along the ventricular zone divide into 
cells that will differentiate into neurons and glia. Radial glia extend processes to the pial surface 
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and freshly-formed neurons climb up the processes into their mature positions where they form 
layers in the optic tectum (Nadarajah, et al., 2001). This process also occurs in mammals. We 
wanted to study how Pcdh19 would affect mechanisms related to the formation of cortex in 
mammals. We hypothesized that Pcdh19 would be important for adhering developing neurons to 
radial glia so they can reach the correct position. 
 Using a 5xUAS-GAL4 system to express LifeAct in Pcdh19-expressing neurons in wild 
type zebrafish shows that Pcdh19-expressing neurons associate in distinct radial columns during 
neurodevelopment (Fig 1A, D). CRISPR RNAs were injected in zebrafish that express the 
LifeAct reporter in Pcdh19-expressing cells at one cell stage to make Pcdh19 knockouts and later 
stages to make Pcdh19 knockdowns simulating the mosaic expression that would result from X- 
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Fig. 1: The number of differentiated neurons 
increases when Pcdh19 is lost. (A) FIJI 
TrakEM2 modeling of pcdh19-expressing 
neurons in the optic tecta of 
pcdh19:GAL4;5xUAS:LifeAct zebrafish at 3dpf. 
(B) FIJI TrakEM2 modeling of pcdh19-
expressing neurons in the optic tecta of 
pcdh19:GAL4;5xUAS:LifeAct  in Pcdh19 KO 
zebrafish at 3dpf. (C)  Quantitative data 
comparing the average neuron counts 
between the WT and pcdh19
-/-
. The graph 
demonstrates a significant increase in the 
neuron count. (D, E) Two-photon images of  
pcdh19:GAL4;5xUAS: LifeAct zebrafish at 3dpf 
in wildtype and Pcdh19 KO, respectively. A 
and B are not models of D and E.  
C 
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inactivation of Pcdh19. Behavioral data of mosaics showed that zebrafish demonstrated 
significant impairment of visual recognition and reaction while wild type and complete Pcdh19 
knockouts did not. Two-photon imaging of LifeAct, which targets GRP to F-actin, in mutants 
lacking Pcdh19 showed loss of columnar organization. There was also increased neurogenesis 
and an increase in the number of neurons expressing Pcdh19 (Fig 1B, E). The mechanism for 
these observations is not known. 
 Numerous signaling pathways through diffusible morphogens or cell-to-cell contacts are 
involved in neuronal differentiation or neurogenesis, such as hedgehog and Notch/Delta 
signaling pathways (Hatakeyama, et al., 2014; Bambakidis, et al., 2012). The Wnt signaling 
pathway is also very important for normal development of nervous tissue. In humans, there are 
nineteen genes that code for Wnt glycoproteins and the ten receptors in the Frizzled family of G-
protein coupled receptors that bind to those ligands (Angers and Moon, 2009). This allows the 
Wnt signaling pathway to be involved in numerous developmental mechanisms including 
neurogenesis, axial patterning, neuronal migration, and cellular differentiation (Zhong, 2008).  
 Wnt signaling is also categorized into beta-catenin dependent and beta-catenin 
independent. Wnt/beta-catenin signaling is the best known pathway and is classified as the 
canonical Wnt pathway, although there are several noncanonical transduction mechanisms 
(MacDonald, et al., 2009). Without Wnt to bind to in the extracellular fluid, beta-catenin is 
phosphorylated by a complex involving Axin, adenomatous polyposis coli (APC), glycogen 
synthase kinase 3 (GSK3),and  casein kinase 1α (CK1α) (Kikuchi, 1999). Phosphorylated beta-
catenin is then ubiquitinated by SKP1–cullin 1–F-box E3 ligase for degradation in the 
proteasome (Angers and Moon, 2009). In other words, lack of Wnt signaling leads to 
degradation of beta-catenin in the cytoplasm. When a Wnt glycoprotein binds to a Frizzled 
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receptor, it recruits low density lipoprotein receptor-related protein 5 or 6 (LRP5 or LRP6) into a 
complex on the membrane (Kikuchi, 1999). Recruitment of Dishevelled protein to the Frizzled 
receptor, and of GSK3-beta to the LRPs leads to phosphorylation of the LRP and binding of 
Axin (Gao and Chen). With Axin in a complex with LRP5 or LRP6, the degradation complex is 
inactivated, and beta-catenin begins accumulating in the cytoplasm and eventually translocates to 
the nucleus where it binds to TCF/LEF family of transcription factors to stimulate transcription 
of genes involved in several processes (MacDonald, et al., 2009; Angers and Moon, 2009).  
 Another important Wnt receptor is Ryk. Ryk is consists of an extracellular domain 
(ECD), transmembrane domain, and intracellular domain (ICD). The extracellular domain uses a 
WIF-type Wnt binding domain. The intracellular domain is a tyrosine kinase that lost its intrinsic 
kinase capabilities (Lu, et al., 2004). Instead, the intracellular domain is cleaved by gamma-
secretase in neural progenitors, and translocation of the ICD to the nucleus leads to activation of 
Wnt target genes (Lyu, et al., 2008). Ryk is involved in activating beta-catenin independent 
pathways when interacting with the Wnt5 and Wnt11 ligands, which regulates axon guidance 
and cell migration (Berndt, et al., 2011). Ryk also binds Wnt3a to activate Wnt/beta-catenin 
leading to neuronal proliferation and differentiation (Lyu, et al., 2008). Ryk is regulated by the 
activity of MIB1, an E3 ubiquitin ligase. MIB1 ubiquitinates Ryk to promote degradation, but it 
can also form a complex with Ryk to activate Wnt/beta-catenin signaling (Berndt, et al, 2011). 
 Ryk’s involvement in Wnt signaling is intriguing because Berndt, et al. (2011) conducted 
a tandem affinity purification of Ryk along with mass spectrometry. They identified numerous 
cellular adhesion proteins in the cadherin superfamily, including several members of 
protocadherins. Protocadherin-19 was one of the binding partners of Ryk, including other 
protocadherins (Berndt, et al., 2011; Kahr, et al., 2013). Additionally, other members of the 
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cadherin superfamily, including protocadherins, have been shown to interact with proteins 
known to be parts of the Wnt signaling pathways (Kahr, et al., 2013; Kim, et al., 2011; Redies, et 
al., 2005; Weiner and Jontes, 2013). This suggests that protocadherins have a legitimate role in 
Wnt signaling. We performed a tandem affinity purification of Pcdh19-TAP and Ryk-GFP. We 
confirmed that Ryk and Pcdh19 formed a complex. Given our data showing zebrafish with 
Pcdh19 knocked down have increased numbers of neurons and increased numbers of Pcdh19-
expressing neurons, it is possible that Wnt3a binding to Ryk regulates proliferation and 
differentiation of Pcdh19-expressing neurons. Since the presence of Pcdh19 in wild type fish 
demonstrate a lower cell count and less Pcdh19 differentiation, Pcdh19 may interact with Ryk to 
inhibit Wnt signaling.  
 
METHODS 
Genetic Recombineering 
 Ryk cDNA for Danio rerio was obtained by RT-PCR from 48 hpf embryos. Restriction 
enzymes were used to insert the cDNA into pEGFP-N1, which is driven by the CMV promoter. 
Plasmids were transformed into TOP10 cells and later concentrated to be used in in vitro 
experiments and embryonic injections. BAC clone CH211-66i8 was obtained from BACPAC 
resources.   BAC clone CH211-66i8 contains the full Ryk genomic locus, and itol2 and Gal4 
were subsequently added.  
PCR Site Mutagenesis 
 Primers were designed to create PCR products that split the transmembrane and 
extracellular domain from the intracellular domain. The design for the primers are listed as 
follows: RykDN-BamHI-R: 5’-CGCGGATCCCCAC…ATGCTGTGGAGT-3’, which inserted a 
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BamHI site at the end of the extracellular domain of Ryk; RykICD-XhoI-F: 5’-
CGCCTCGAGGCCA…AATGGATGACAGC-3’ which inserted a XhoI site in front of the 
intracellular domain of Ryk; RykFix-F: 5’-ATTCACAAAGACTTGGCTGCC-3’; RykFix-R: 5’-
CAAGTCTTTGTGA…TGACCTCTCTCCG-3’ to fix the mutation in the gene. 
CRISPR 
 Clustered regularly-interspaced short palindromic repeats (CRISPR) were designed 
against several segments in exon 1 of Ryk to create a transgenic Ryk knockout. Sites were 
selected directly upstream of a NGG PAM site. Single stranded antisense oligos were ordered 
from, annealed using PCR, and then TOPO cloned into a pDR274 plasmid vector. The CRISPR 
was designed against the sequence, 5’-GCGGCGTCGGCGGTGTCCCGGGG-3’. The two 
antisense oligos were 5’-TAGCGGCGTCGGCGGTGTCCCGGGG-3’ and 5’-
AAACCCCCGGGACAC CGCCGACGCC-3’. CRISPR guide RNAs were transcribed using the 
MAXIscript ® T7 kit by Ambion and Cas9 RNA was transcribed using the mMESSAGE 
mMACHINE kit by Ambion. Guide RNAs and Cas9 RNAs were injected in 1-cell and 2-cell 
stage embryos.  
Genotyping 
 CRISPR sites were strategically chosen because of the existence of a SmaI restriction site 
at the first cut sequence. CRISPR-injected zebrafish were screened by digesting embryos and 
tailfins in 100 uL 50mM NaOH for 10 minutes at 95°C. Then, 10 uL of 1M Tris pH 8 was added 
to neutralize the digestion. PCR of the digested DNA was performed, followed by the 
appropriate restriction digest, and then analyzed on an agarose gel. Two cut bands indicated that 
the CRISPR didn’t work, but a protected band indicated that it was a success. Primers for PCR of 
the NaOH-digested DNA were as follows: Ryk-test-F 5’-TTTTGGATGAGGTTCCGTGG-3’ 
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and Ryk-test-R 5’-GTTTCTTGACCTCTTCCTCG-3’. High resolution melt analysis was also 
performed to corroborate restriction digest results. Additional primers were designed for a 
smaller amplicon. Primers designed around the CRISPR site for HRMA were 5’-
TCCACAGGCCATCTCTCAGC-3’ and 5’-GTCTGTGATCTTGACTTGCATGC-3’.  
Zebrafish Maintenance 
 Zebrafish were maintained at 28°C while being fed twice daily with fish food and brine 
shrimp. Wild type and transgenic lines were crossed according to the method detailed by 
Westerfield (1995). Embryos were collected and grown in E3 embryo media in a 28°C incubator 
for one week, then transferred to fish tanks.  
Cell Culture 
 HEK293 cells were obtained from ATCC. Cells were cultured in Dubecco’s Modified 
Eagle’s Medium (DMEM) with 10% Fetal Bovine Serum (FBS). At 80% confluence, cells were 
transfected using a calcium-phosphate transfection method. 2xHBS was added to an equal 
volume of water, DNA (4% by mass), and 2M CaCl2 (12.2% by volume). The following day 
cells were used. 
Co-immunoprecipitation 
 Transfected HEK cells were lysed in lysis buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 
0.5% Triton X-100, 1 mM PMSF, and protease inhibitor from Roche). Lysates were incubated 
with the appropriate GFP, HA, or IgG beads overnight at 4°C. Lysates were then centrifuged at 
4°C for 10 min, and identical volumes were loaded into two wells per condition onto NuPAGE 
10% Bis-Tris SDS-PAGE gels purchased from Life Technologies. After electrophoresis, proteins 
were transferred to PVDF membrane from GE Healthcare in transfer buffer from Bio-Rad 
laboratories. Blots were blocked with 5% nonfat milk in TBST (10 mM Tris-HCL, pH 7.6, 100 
16 
 
mM NaCl, and 0.1% Tween-20) and incubated overnight at 4°C with primary antibody (rabbit 
anti-GFP from Life Technologies at 1:1250; mouse anti-HA at 1:5000; mouse anti-strep tag from 
Millipore at 1:2500; mouse anti-myc from Millipore at 1:2500; mouse anti-V5 from Genscript at 
1:2500). Anti-mouse and anti-rabbit HRP-conjugated secondary antibodies from Jackson 
ImmunoResearch Laboratories were added at a concentration of 1:5,000. PerkinElmer’s Western 
Lightning Ultra kit was used to develop a chemiluminescent signal on the blots, which were 
imaged using the UltraLum imaging system. 
Immunocytochemistry 
 Transfected HEK293 cells were fixed for 10 mins in 4% paraformaldehyde in PBS. Cells 
were washed in PBS then permeabilized with 0.025% Triton X-100 in PBS. Cells were then 
blocked overnight in PBS, 0.5% Triton X-100, 1% DMSO, 10% normal goat serum and primary 
antibody at a dilution of 1:50 antibody (rabbit anti-GFP from Life Technologies; mouse anti-HA; 
mouse anti-strep tag from Millipore; mouse anti-myc from Millipore). Cells were then blocked in 
PBS, 0.5% Triton X-100, 1% DMSO, 10% normal goat serum and anti-mouse and anti-rabbit 
secondary antibody Dylight 488 and 549 at a dilution of 1:50 antibody. Fluoromount G was 
placed on microscope slides, and the coverslips were placed on the Fluoromount G to preserve 
cells for future imaging. Phosphone-histone3 staining was conducted to measure proliferation. 
Wild type and mutant larva at various time points were fixed in 4% paraformaldehyde in PBS.  
They were permeabilized in PBS + 0.25% Triton X-100 and later incubated in block (PBS, 1.5% 
BSA, 2% NGS, PBS) with α-PH3 antibody from Cell Signaling. The samples were later blocked 
with secondary α-rabbit Dylight 488 antibody for visualization. 
Two-photon microscopy and image analysis. 
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 Two-photon imaging fixed zebrafish at 24 hpf was performed at room temperature on a 
custom-built microscope. Excitation was provided by a Chameleon-XR Ti :Sapphire laser 
(Coherent). Fluorescence was detected using a Multiphoton Detection Unit mounted on a 
SliceScope (Scientifica). Water immersion objectives from Olympus were used, either 
60×/NA1.0 (LUM PLFLN60X/W) or 20×/NA1.0 (XLU MPLFLN20XW). Image analysis was 
performed with Fiji. Stack of approximately 40 optical sections were imaged from WT or 
Pcdh18b mutants. Stacks were assembled into 3D images so that positive cells could be counted.  
 
RESULTS 
Before experiments could be conducted, the Ryk gene for Danio rerio had a point mutation that 
resulted in a lysine to glutamate transition at the 460th amino acid. Primers were purchased to 
perform PCR site mutagenesis to un-mutagenize the gene, which was completed after several 
attempts. Lyu et al. (2008) showed that Ryk transduced its signal through the cleavage of the 
intracellular domain and its translocation to the nucleus to initiate genes involved in neuronal 
differentiation. To further understand the mechanism and Pcdh19’s effect on Ryk-mediated Wnt 
signaling, PCR site mutagenesis was again performed to create a dominant-negative Ryk 
(RykDN) and an intracellular domain of Ryk (RykICD). RykDN consisted of the extracellular 
WIF binding domain and transmembrane domain so that it remained on the plasma membrane. 
RykDN could bind any potential ligand or co-receptor, but does not transmit a signal. RykICD 
contains the nonfunctional tyrosine kinase domain, undergoes nuclear translocation, and initiates 
transcription.  
 Berndt, et al (2011) demonstrated that Ryk formed a complex with many proteins, 
including Pcdh19 and other protocadherins. We wanted to confirm that Ryk actually interacted 
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with Pcdh19 through coimmunoprecipitation. HEK293 cells were cultured and transfected with 
plasmids containing Pcdh19-TAP and GFP-conjugated Ryk constructs. Staining on blots showed  
 
 
Fig. 2 Coimmunoprecipitations of Pcdh19-TAP and Ryk-GFP (A), RykDN-GFP (B), RykICD-GFP (C). The first row used antibody to 
stain against the streptactin domain on the Tandem Affinity Purity (TAP) tag to show that Pcdh19 was expressed in the 
appropriate cultures. The second row used antibody to  stain against the GFP tag on Ryk, and RykDN, and RykICD to show an 
interaction or lack there of between Pcdh19 and the Ryk construct. (B) Exposure was blown out to better show the interaction 
band.  
 
that Pcdh19 does interact with Ryk through its extracellular domain (Fig 2). Because Ryk was 
previously shown to bind to many proteins, extremely bright bands due to lots of binding were 
not expected (Fig 2). Many attempts were done to improve the cleanliness and definition of the 
co-immunoprecipitations, but to no avail. Failure to optimize the co-immunoprecipitations  
prevented proceeding cell fractionation experiments to further understand Pcdh19’s influence on 
Ryk-mediated signaling. 
 Immunostaining was performed to understand how Pcdh19 affects Ryk-mediated Wnt 
signaling. HEK cells were transfected with the Ryk constructs alone, or in conjunction with 
Pcdh19, Wnt3, a ligand involved in neuronal differentiation, or all three. Nuclei were illuminated  
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Fig. 3 Immunohistochemistry to elicit and confirm Ryk mechanism. HEK293 cells transfected with the indicated genes. GFP 
tags on Ryk constructs and myc tags on Pchd19. Anti-rabbit antibody conjugated with Dylight 488 interacted with anti-GFP to 
illuminate the Ryk constructs as green. Anti-mouse antibody conjugated with Dylight 550 interacted  with anti-myc to illuminate 
the Pcdh19 as red. DAPI stain (blue) shows the nuclei.  
 
using a DAPI stain, and α-GFP and α-myc antibodies were used against the Ryk constructs and 
Pcdh19 respectively. Secondary antibodies were used to illuminate Ryk constructs in green and 
Pcdh19 in red. Ryk constructs expressed individually displayed protein as expected. RykDN was 
localized to the cellular membrane (Fig 2I), and RykICD was localized to the cytoplasm and 
nucleus. Ryk was predominantly found on the plasma membrane (Fig2E). However, there was  
minor green expression in the cytoplasm and nucleus, likely resulting from endogenous γ-
secretase activity. Because the GFP tag was attached to the C-terminus, fluorescence followed 
the position of the intracellular domain (Fig 2A). Additionally, Ryk and Pcdh19 cotransfections 
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indicate that they do interact, and that Pcdh19 inhibits nuclear translocation of the RykICD as 
evidenced by less green fluorescence in the nucleus between Fig 2A and 2C. 
 In vitro results were intriguing, but in vivo experiments are needed to confirm 
mechanisms elucidated in vitro and their place in the grand scheme of neurodevelopment. Oligos  
from which CRISPR RNAs were created and injected along with Cas9 mRNAs into single-celled 
embryos. The goal was to create a Ryk KO and cross them with Pcdh19:Gal4;5xUAS:Lifeact  
wildtype and Pcdh19 KO zebrafish to study the effects of neuronal proliferation, differentiation, 
and columnar organization. F0s were screened using PCR of the CRISPR site, then a test digest 
with XmaI which had a cut site within the CRISPR site. The PCR band would be protected if the 
CRISPR worked, or the band would be cut in half if unsuccessful. This method demonstrated 
that CRISPR worked to some extent. At least, some fish appeared to be mosaic Ryk KOs. If the 
mutation occurred in the germline, then it could be passed to the following generation. High 
resolution melt analysis (HRMA) also seemed to indicate that it worked. However, genotyping in  
the F1 generation was not promising. Both the digests and HRMA seemed inconclusive at best. 
Multiple efforts resulted in the decision that the CRISPR was unsuccessful. A Ryk BAC was 
being developed, but this endeavor was dropped when it was known that a Ryk KO zebrafish 
couldn’t be achieved in a timely manner. 
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 Because protocadherins could act similarly and be responsible for a combinatorial code 
that assemble stereotyped connections and other protocadherins have been shown to interact with 
Ryk, we performed phospho-histone H3 staining to compare proliferation between protocadherin 
18b (Pcdh18b) knockouts and wildtypes. Wildtype and mutant progeny were stained at 24 hpf. 
There was a statistical difference between the two categories where Pcdh18b mutants displayed 
slightly more mitotic events indicative of proliferation, although these results are not noticeable 
by mere looking at the images (wild type: 129.75±7.96, n=12; mutant: 143.56±12.02, n=9; 
P=0.045, student’s t-test). 
Fig. 4 Using CRISPR against Ryk to make a knockout line with which to do in vivo studies. (A,B) Test digests of 
PCR amplicons containing the Ryk CRISPR site for F0 and F1, respectively. F0 appeared to work, but F1 did not appear 
so. In A, the first half of wells represent test digests, and the rest are the PCRs before the digests. (C) HRMA of zebrafish 
injected with a CRISPR against Ryk. The red lines indicate wild types and injected fish that didn’t not receive a genetic 
lesion. The deflections indicate that the CRISPR worked in some fish.  (D) HRMA of F1 generation of fish that have Ryk 
CRISPR’ed. The results are messy and confirm that the CRISPR didn’t work.  
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Fig 5: Phospho-histone H3 staining. Staining was performed to compare proliferation in WT (A) and Pcdh18b mutants (B). The 
number of cells in a stack of images were counted as shown by the graph (C). The data indicated that Pcdh18b had statistically 
more proliferating cells than WT (wild type: 129.75±7.96, n=12; mutant: 143.56±12.02, n=9; P=0.045, student’s t-test). 
 
DISCUSSION AND FUTURE DIRECTIONS 
 Preliminary experiments showed that Ryk and Pcdh19 do interact. The extracellular 
domain of Ryk is required for the interaction. Pcdh19 likely binds at Ryk’s extracellular domain 
to inhibit the binding of Wnts, thereby inhibiting Wnt signaling. Immunostaining seemed to 
support this hypothesis. However, more attempts are required to take more pictures and quantify 
signals to determine overlap in the membrane or nucleus. Stronger and consistent bands between 
Pcdh19 and Ryk or RykDN would be desirable. Using confocal imaging during 
immunocytochemistry would yield clearer results with regards to nuclear translocation. Also, it 
proved difficult to keep the HEK cells on the coverslip, which led to very few samples to image. 
Despite numerous efforts and troubleshooting, basic immunostaining and Co-IPs proved 
difficult. There were many setbacks that prevented the initiation of other experiments, such as 
cellular fractionation for western blots. Although, lab personnel managed to obtain a clean Co-IP 
between Ryk and Pcdh18b, adding further weight to the idea that there is a molecular 
relationship between protocadherins and Ryk (unpublished and not pictured). 
 Phospho-histone H3 staining of wildtype and Pcdh18b mutant zebrafish showed modest 
but statistically significant increases in the number of proliferating cells. As stated earlier, it 
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appears that other protocadherins regulate proliferation. Similar experiments in zebrafish of 
various protocadherin knockouts would support or reject this hypothesis. Given the overlapping 
spread in data between the wildtypes and Pcdh18b mutants, it would probably be worthwhile to 
repeat the experiment to more clearly show a difference in proliferation, despite already 
establishing statistical significance. 
 After further investigation, it was determined that the first CRISPR failed because it was 
designed improperly. The PAM site was mistakenly included in the gRNA. The PAM site was to 
remain just downstream of the CRISPR site and not part of the site itself. A new CRISPR site 
has been chosen and development of the Ryk knockout is underway. 
 Although many of the experiments didn’t work, the hypothesis that Pcdh19 interacts with 
Ryk to regulate neuronal proliferation should be pursued further. Because Ryk has been shown 
to interact with other protocadherins, this mechanism could be a significant factor in total 
proliferation in the central nervous system, especially in complex, layered brain regions (Berndt, 
et al., 2011). To save funds and resources, in vitro experiments should be paused. Efforts should 
be directed at pursuing a Ryk knockout zebrafish line. Ryk knockout fish and be crossed with 
transgenic lines of different protocadherin knockouts, including a Pcdh19 knockout. If the 
mutant phenotype is rescued in the progeny, then it confirms that the Pcdh19-Ryk interaction is 
crucial for neurogenesis and columnar organization. 
 In the meantime, it would be worthwhile to revisit the EFMR disease mechanism from 
another perspective. Previously, the lab described a cis complex between Pcdh19 and N-cadherin 
(Ncad) that significantly enhance the homophilic adhesive capabilities of Pcdh19 (Emond, et al., 
2011). The Pcdh19-Ncad complex only binds to other Pcdh19-Ncad complexes via Pcdh19 
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homophilic binding. The complex does not bind to Ncad itself, nor does the Pcdh19-Ncad 
complex bind to complexes of N-cadherin and other protocadherins. 
 Previously, this complex was studied to determine a mechanism for neurulation defects 
(Biswas, et al., 2010). Research had shown that mutant Pcdh19 or mutant Ncad led to similar 
malfunctions in neurulation and brain morphogenesis. Emond, et al. (2011) acknowledged the 
lack of a Pcdh19-Ncad complex using Pcdh19 mutants seen in EFMR patients as a functional 
defect of EFMR. However, there have been no other results or findings in the literature that elicit 
the molecular mechanism for EFMR, other than the aforementioned benefits of corticosteroids. 
Numerous papers hypothesize that cellular interference as a result of X-inactivation leads to a 
scrambled signal that manifests itself as epilepsy (Redies, et al. 2012; Harssel, et al., 2013; 
Dibbens, et al. 2008; Leonardi, et al., 2014). Again, pathways responsible are unknown.  
 It is possible that the mechanism for cellular interference due to X-inactivation is actually 
known. Imagine a field of cells, like the one below (Fig 6). In females with two normal copies or 
males with one normal copy, cells would likely adhere via a Pcdh19-Ncad complex (Fig 6A). In 
females with two mutant copies or males with one mutant copy, the cell may adhere via Ncad-
Ncad interactions or other adhesive proteins (Fig 6B). In the case of EFMR patients in which a 
female has one normal copy and one mutant copy, some cells would have Pcdh19-Ncad cis 
complexes, and others would not (Fig 6C). If cellular adhesion behaves similarly to in vitro 
experiments, some cells would adhere together via the Pcdh19-Ncad complex, but other cells 
could not adhere because Ncad or Pcdh19 alone does not exhibit strong adhesion with the cis 
complex. Theoretically, half the developing neurons would be unable to bind to each other or 
demonstrate only weak adhesion. Cellular migration likely requires strong adhesion amongst 
cells. The lack of strong connections due to random cells expressing mutant Pcdh19 could 
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disrupt migration seen during neurulation or when neurons migrate along radial glia to mature 
positions (Biswas, et al. 2010; Cooper, et al; 2015).  
 
Fig. 6: A schematic of X-linked inactivation as it pertains to expression patterns. (A, B) Normal or mutant Pcdh19 will be 
expressed ubiquitously in homozygotes, even with X-linked inactivation. (C) Heterozygotes for Pcdh19 will result in individual 
cells stochastically expressing either form due to X-linked inactivation, leading to mosaicism in neuronal tissue. 
 
 The next step is to determine the downstream effects of failed adhesion due to the 
decrease in Pcdh19-Ncad complexes and how they relate to EFMR. The trick to relating findings 
to EFMR is that results must be unique to zebrafish that are heterozygotes for mutant Pcdh19 or 
mosaically express Pcdh19. Since increased neuronal proliferation was discovered in Pcdh19 
heterozygotes and knockouts, proliferation is likely not the only mechanism that leads to EFMR 
symptoms. It may play a part and still demonstrates Pcdh19’s role in neurogenesis, but there are 
likely other pathways that contribute to the manifestation of the disease. Previously, morpholinos 
were used against Pcdh19 to study neurulation (Biswas, et al., 2010). Since morpholinos can 
have a varied effect, the published results were possibly due to mosaic expression. Similar 
experiments should be conducted in Pcdh19 knockouts to see if there are similar defects in 
neurulation. If not, then faulty neurulation during development may lead to EFMR.  
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 The proliferation phenotype is also very significant and should be investigated in its 
relation to the Pcdh19-Ncad complex. The literature shows that cadherin-mediated adhesion is 
critical for regulating neurogenesis through the Notch-Delta pathway (Hatakeyama, et al. 2014). 
Using a DN-cadherin to disrupt adherins junctions, they showed an increase in the number of 
neurons, similar to the results shown by Cooper et al. (2015). Mosaicism of Pcdh19 mutants may 
lead to faulty adhesion at adherins junctions. Without proper contact between cells, progenitors 
and neurons would be unable to maintain cell-to-cell signaling through Notch, which would lead 
to increased neurogenesis due to the lack of inhibitory signal.  
 It’s also worth noting that N-cadherin binds to β-catenin which complexes with α-catenin 
which binds to the cytoskeleton to support N-cadherin mediated adhesion (Aberle, et al., 1996; 
Gooding, et al., 2004; Huang, et al., 2014; Miyamoto, et al., 2015). β-catenin is also a well-
characterized component of the Wnt/β-catenin signaling pathway which regulates proliferation 
(Angers and Moon; 2009; Kikuchi, 1999; MacDonald, et al., 2009). Before conducting a 
literature review, the general hypothesis was that lack of N-cadherin mediated adhesion, such as 
would be seen in a cell expressing only N-cadherin tried to connect with a cell expressing a 
Pcdh19-Ncad complex, would lead to increased neuronal differentiation. Although there was 
promise to this idea, it became apparent that this multistep pathway was rather complicated. 
 Initially, it appeared that adhesion through N-cadherin led maintenance of a progenitor 
phenotype (Miyamoto, et al., 2015. One mechanism was through the activation of AKT which 
phosphorylated β-catenin at the Ser-522 residue and phosphorylated GSK3β (Zhang, et al., 
2013). This species of phosphorylated β-catenin went to the nucleus to mediate signaling, and the 
phosphorylated GSK3β becomes inactivated which allows the accumulation of β-catenin in the 
cytosol and eventually the nucleus. β-catenin signaling was associated with the maintenance of a 
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self-renewal phenotype (Zhang, et al., 2010; Noles and Chenn, 2007; Wrobel et al., 2007; 
Sinevas and Pospelov, 2014). In relation to the canonical Wnt/ β-catenin pathway, there was the 
possibility that adhesion might lead to cleavage of the intracellular domain that releases β-
catenin into the cytosol where it accumulates until it transduces the signal. N-cadherin actually 
forms a complex with presenilin 1 (PS1) in addition to β-catenin (Georgakopoulos, et al., 1999; 
Uemura, et al., 2007). Presenilin 1 is the catalytic component of γ-secretase which also cleaves 
Notch and Ryk (Hatakeyama, et al., 2014; Lyu, et al. 2008). Researchers studied PS1 cleavage of 
Ryk and if that influences neuronal differentiation. In fact, lack of cleavage led to less β-catenin 
signaling, and there was an increase in neuronal differentiation and migration (Jang, et al., 2011). 
It appears that adhesion leads to β-catenin signaling and maintenance of a self-renewal 
phenotype. Adhesion could also lead to cleavage by PS1 to release free β-catenin into the cytosol 
to further induce signaling. After cleavage of N-cadherin, PS1 may be free to cleave Notch to 
add redundancy to the signal for a self-renewing precursor phenotype (Georgakopoulos, et al., 
1999). If adhesion by N-cadherin induced cleavage by PS1, it would be reasonable to 
hypothesize that Pcdh19 affects neuronal differentiation and migration through its complex with 
Ncad. When some cells don’t have Pcdh19 to form the Pcdh19-Ncad complex, then cells would 
lack adhesive contacts which would reduce Notch and β-catenin signaling, leading to 
differentiation and migration. 
 However, there are more pieces to the puzzle. Before PS1 can cleave the intracellular the 
domain, ADAM10, a metalloprotease, must cleave and shed the extracellular domain (Saftig and 
Lichtenthaler, 2015; Reiss, et al., 2005; Malinverno, et al., 2010; Uemura, et al., 2006). When 
this occurs, cells demonstrate less adhesion (Reiss, et al., 2005). Eliminating cleavage activity 
leads to stronger adhesion and more β-catenin localized at the cell membrane. These findings 
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conflict with what was already discussed (Zhang, et al., 2010; Noles and Chenn, 2007; Wrobel et 
al., 2007; Sinevas and Pospelov, 2014). Ideally, adhesion would lead to more intracellular 
cleavage and less localization of β-catenin at the plasma membrane to maintain a self-renewal 
phenotype. If the conflicting results are correct, then increased adhesion would lead to less β-
catenin signaling and more differentiation. This process is contrary to what was previously 
outlined. The cause for ADAM10 cleavage of Ncad during development wasn’t found in the 
literature, but it was mentioned that NMDA receptor stimulation would induce Ncad cleavage by 
ADAM10 (Maliverno, et al., 2010; Marambaud, et al., 2003). It was proposed that this might 
somehow be involved in learning, although it is unclear how the elimination of contact following 
a signal would improve learning. It should also be noted that in more mature neurons, Ncad is 
found at synapses (Basu, et al., 2015; Jontes, et al., 2004; Maliverno, et al., 2010; Marambaud, et 
al., 2003, Georgakopoulos, et al. 1999). The inability of synapses to form between cells with 
Pcdh19-Ncad complexes and cells with only functioning Ncad may somehow be responsible for 
the epilepsy in EFMR patients, especially if additional functions are linked to NMDA receptors. 
However, this possibility wasn’t really explored while reading the literature because it likely 
does not regulate neurogenesis. 
 Another paper had some strange findings. Overexpressing full-length or a dominant-
negative N-cadherin without the extracellular domain led to more differentiation and less 
precursors, which was shown to be the result of less β-catenin signaling (Noles and Chenn, 
2007). This indicates that β-catenin signaling is independent of adhesion but related to the 
amount of Ncad. Interestingly, these researchers distinguished that the decrease in β-catenin 
signaling resulted in an increase in neuron-neuron daughter cells, as opposed to precursor-
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precursor or precursor-neuron proliferation. More specifically, there was an increase in the 
number of daughter intermediate precursors and a decrease in the number of daughter radial glia. 
 Trying to uncover Ncad’s role in proliferation is not very clear and is even contradictory 
at times. However, adhesion or the lack of adhesion by Ncad due to stochastic expression of 
normal or mutant Pcdh19 could affect signaling pathways that regulate proliferation and 
differentiation and explain the lab’s prior results. However, the literature review elucidated the 
need for future research to be very thorough and consistent with definitions and experimental 
parameters. For example, an observed increase in proliferation or neurogenesis could be the 
result of increasing the number of precursors, or it could be due to early cell cycle exit into a 
mature neuronal phenotype. These two possibilities are the result of different pathways or 
opposite results of the same pathway. Lack of stringency with terms can lead to confusion due to 
apparent conflict among the findings in various labs. Also, cell types need to be more accurately 
defined. As a progenitor or neuron progresses, minor nuances in its phenotype can change so that 
a single mechanism can have varying results at different time points (Gotz and Huttner, 2005; 
Miyamoto, et al., 2015; Noles and Chenn, 2007; Huang et al., 2015). Studies of the evolution of 
mechanisms over time, especially during development, would likely be useful. One review 
article admitted that β-catenin could have opposite effects on development depending on the 
stage of development in which it’s studied (Sineva and Pospelov, 2014). 
 Another area of potential interest is how cell polarity can regulate polarity. Cell-fate as a 
result of symmetric and asymmetric divisions are based in the concept of cell-polarity. Some 
research suggests the importance of cell-polarity on how adherens junctions regulate 
proliferation or differentiation (Gotz and Huttner, 2005; Miyamoto, et al., 2015). Perhaps, 
Pcdh19 mutants could disrupt these mechanisms (Compagnucci, et al., 2015). However, there is 
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the possibility that the proliferative phenotype in PCdh19 KOs is totally independent of a 
contact-dependent mechanism. If there is no functioning PCDH19, then adhesion among all cells 
would presumably act through N-cadherin, which is potentially why there are no symptoms in 
Pcdh19 negative males and females. However, this assumption has been untested and should be 
answered before investigating the mechanisms above. It’s possible that mutant Pcdh19 can form 
cis complexes with N-cad but can’t adhere to other complexes which could lead to a proliferative 
phenotype. Alternatively, Pcdh19-regulated neurogenesis could be due to soluble factors that 
initiate signals, such as Ryk-mediated Wnt-signaling. The intracellular domain of Ryk was 
shown to bind to β-catenin, which could explain Ryk’s role in Wnt signaling (Berndt, et al., 
2011; Tourette, et al., 2014) 
 Another reason to revisit the Pcdh19-Ncad complex is that it may serve as a model for the 
manner in which protocadherins may serve as a combinatorial code (Krishna, et al., 2011). Ncad 
would act as a co-adhesive protein through which signals related to neurogenesis or 
synaptogenesis could be propagated. The protocadherins act as discriminating adhesive protein 
that will only bind homophilically and guides neurons to connect only with the appropriate 
partners. There are so many potential questions to be answered to better understand neurogenesis 
through the lens of protocadherins and cadherins and to decipher the molecular mechanism 
behind EFMR. This research has been incredibly interesting due to its novelty and huge 
implications on major neurodevelopmental processes of which current knowledge only has a 
fractured understanding. 
 
 
 
31 
 
ACKNOWLEDGEMENTS 
I would like to thank Dr. James Jontes for the opportunity to work in his lab experience research 
and the chance to make an impact on the scientific community. I am also extremely grateful for 
his mentoring and guidance to help develop a hypothesis, choose experiment, and navigate 
around setbacks. I would like to thank Dr. Michelle Emond, Sharon Cooper, Zachary Morrow, 
and Min An for their abundant assistance with providing insight and troubleshooting 
experiments. I would like to thank the Undergraduate Research Office at The Ohio State 
University for a Summer Research Funding Award and the Honors department within the School 
of Health and Rehabilitation Sciences for their financial support as well. I also want to thank Dr. 
Jontes, Dr. Christine Beattie, and Dr. Christopher Taylor for serving as my thesis committee. 
 
REFERENCES 
Aberle, H., Schwartz, H., and Kemler, R. (1996). Cadherin-catenin complex: protein interactions 
and their implications for cadherin function. J Cell Biochem. 61(4): 514-523. 
Ahn, J., Jang, J., Choi, J., Lee, J., Oh, S. H., Lee, J., Yoon, K., Kim, S. (2014). GSK3β, but not 
GSK3α, inhibits the neuronal differentiation of neural progenitor cells as a downstream 
target of mammalian target of rapamycin complex1. Stem Cell Dev. 23(10): 1121-33. 
Angers, S., Moon, R. (2009). Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol. 
10(7): 468-477. 
Bambakidis, N. C., Onwuzulike, K. (2012). Sonic Hedgehog signaling and potential therapeutic 
indications. Vitam Horm. 88: 379-394.  
Basu, R., Taylor, M. R., and Williams, M. E. The classical cadherins in synaptic specificity. Cell 
Adh Migr. 9(3): 193-201.  
Biswas, S., Emond, M. R., Jontes, J. D. (2010). Protocadherin-19 and N-cadherin interact to 
control cell movements during anterior neurulation. J Cell Biol. 191(5): 1029–1041. 
Camacho, A., Símon, R., Sanz, R., Viñuela, A., Martinez-Salio, A., and Mateos, F. (2012). 
Cognitive and behavioral profile in females with epilepsy with PCDH19 mutation: Two 
novel mutations and review of the literature. Epilepsy and Behavior. 24(1): 134-137. 
Compagnucci, C., Petrini, S., Higuraschi, N., Trivisano, M., Specchio, N., Hirose, S., Bertini, E., 
Terracciano, A. (2015). Characterizing PCDH19 in human induced pluripotent stem cells 
(iPSCs) and iPSC-derived developing neurons: emerging role of a protein involved in 
controlling polarity during neurogenesis. Oncotarget. 6(29): 26804-26813. 
32 
 
Cooper, S. R., Emond, M. R., Duy, P. Q., Liebau, B. G., Wolman, M. A., and Jontes, J. D. 
(2015). Protocadherins control the modular assembly of neuronal columns in the 
zebrafish optic tectum. J Cell Biol. (211)4: 807-804. 
Depienne, C., Trouillard, O., Bouteiller, D., Gourfinkel-An, I., Poirier, K.,  Rivier, F., Berquin, 
P.,  Nabbout, R., Chaigne, D., Steschenko. D., Gautier, A., Hoffman-Zacharska, D., 
Lannuzel, A., Lackmy-Port-Lis, M.,  Maurey, H., Dusser, A., Bru, M., Gilbert-
Dussardier, B., Roubertie, A., Kaminska, A., Whalen, S., Mignot, C., Baulac, S., Lesca 
G., Arzimanoglou, A., and LeGuern E. (2011). Mutations and Deletions in PCDH19 
Account for Various Familial or Isolated Epilepsies in Females. Hum Mutat. 32(1): 
1959–1975. 
Depienne, C. and LeGuern, E. (2012). PCDH19-Related Infantile Epileptic Encephalopathy: An 
Unusual X-Linked Inheritance Disorder. Human Mutation. 33(4): 627-634. 
Dibbens, L., et al. (2008). X-linked protocadherin 19 mutations cause female-limited epilepsy 
and cognitive impairment. Nature Genetics. 40(6): 776-781. 
Duszyc, K., Terczynska, I., Hoffman-Zacharska, D. (2015). Epilepsy and mental retardation 
restricted to females: X-linked epileptic infantile encephalopathy of unusual inheritance. 
J Appl Genet. 56(1): 49-56. 
Emond, M. R., Biswas, S., Blevins, C. J., Jontes, J. D. (2011). A complex of protocadherin-19 
and N-cadherin mediates a novel mechanism of cell adhesion. J Cell Biol, 195(7), 1115-
1121. 
Emond, M. R., Biswas, S., Jontes, J. D. (2009). Protocadherin-19 is essential for early steps in 
brain morphogenesis. Dev Biol. 334(1): 72-83. 
Gao, C., Chen, Y. (2010). Dishevelled: the hub of Wnt signaling. Cell. Signal. 22(5): 717-727. 
Georgakopoulos, A., Marambaud, P., Efthimiopoulos, S., Shioi, J., Cui, W., Li, H. C., Schutte, 
M., Gordon, R., Holstein, G. R., Martinelli, G., Mehta, P., Friedrich, V. L. Jr., and 
Robakis, N. K. (1999). Presenilin-1 forms complexes with the cadherin/catenin cell-cell 
adhesion system and is recruited to intercellular and synaptic contacts. Mol Cell. 4(6): 
893-902. 
Gooding, J. M., Yap, K. L., and Ikura, M. (2004). The cadherin-catenin complex as a focal point 
of cell adhesion and signaling: new insights from three-dimensional structures. 26(5): 
497-511. 
Gotz, M. and Huttner, W. B. (2005). The cell biology of neurogenesis. Nat Rev Mol Cell Biol. 
6(10): 777-788. 
Harris, M. J., Juriloff, D. M. (2007). Mouse Mutants With Neural Tube Closure Defects and 
Their Role in Understanding Human Neural Tube Defects. Birth Defects Res A Clin Mol 
Teratol. 79(3): 187-210. 
Harssel, J. J. T., Weckhuysen, S., van Kempen, M. J. A., Hardies, K., Verbeek, N. E., de Kovel, 
C. G. F., Gunning, W. B., van Daalen, E., de Jonge, M. V., Jansen, A. C., Vermeulen, R. 
J., Arts, W. F. M., Verhelst, H., Fogarasi, A., de Rijk-van Andel, J. F., Kelemen, A., 
Lindhout, D., De Jonghe, P., Koeleman, B. P. C., Suls, A. Brilstra, E. H. (2013). Clinical 
and genetic aspects of PCDH19-related epilepsy syndromes and possible role of PCDH19 
mutations in males with autism spectrum disorders. Neurogenetics. 14(1): 23-34. 
Hatakeyama, J., Wakamatsu, Y., Nagafuchi, A., Kageyama, R., Shigemoto, R., Shimamura, K. 
(2014) Cadherin-based adhesions in the apical endfoot are required for active Notch 
signaling to control neurogenesis in vertebrates. Development. 141: 1671-1682. 
33 
 
He, Y., Zhang, P. Z., Sun, D., Mi, W. J., Zhang, X. Y., Cui, Y., Jiang, X. W., Mao, X. B., Qiu, J. 
H. (2014). Wnt1 from cochlear schwann cells enhances neuronal differentiation of 
transplanted neural stem cells in a rat spiral ganglion neuron degeneration model. Cell 
Transplant. 23(6): 747-760. 
Hertel, N., Krishna, K., Neurnberger, M., and Redies, C. (2008). A cadherin-based code for the 
divisions of the mouse basal ganglia. J Comp Neurol. 508(4): 511-528. 
Higurashi N, Nakamura M, Sugai M, Ohfu M, Sakauchi M, Sugawara Y, Nakamura K, Kato M, 
Usui D, Mogami Y, Fujiwara Y, Ito T, Ikeda H, Imai K, Takahashi Y, Nukui M, Inoue T, 
Okazaki S, Kirino T, Tomonoh Y, Inoue T, Takano K, Shimakawa S, Hirose S. (2013). 
PCDH19-related female-limited epilepsy: further details regarding early clinical features 
and therapeutic efficacy. Epilepsy Res. 106(1-2): 191-199. 
Higurashi, N., Takahashi, Y., Kashimada, A., Sugawara, Y., Sakuma, H., Tomonoh, Y., Inoue, 
T., Hoshina, M., Satomi, R., Ohfu, M., Itomi, K., Takano, K, Kirino, T, and Hirose, S. 
(2015). Immediate suppression of seizure clusters by corticosteroid in PCDH19 female 
epilepsy. Seizure. 27: 1-5. 
Huang, T., Li, L., Moalim-Nour, L., Jia, D., Bai, J., Yao, Z., Bennett, S. A. L., Figeys, D., and 
Wang, L. (2015). A Regulatory Network Involving β-catenin, E-cadherin, PI3K/Akt, and 
Slug Balances Self-renewal and differentiation of human pluripotent stem cells in 
response to Wnt signaling. Stem Cells. 33(5): 1419-1433. 
Jang, C., Choi, J. K., Na, Y. J., Jang, B., Wasco, W., Buxbaum, J. D., Kim, Y. S., and Choi, E. 
K. (2011). Calsenilin regulates presenilin 1/γ-secretase-mediated N-cadherin ε-cleavage 
and β-catenin signaling. FASEB J. 25(121): 4174-4183. 
Jontes, J. D., Emond, M. R., and Smith, S. J. (2004). In vivo trafficking and targeting of N-
cadherin to nascent presynaptic terminals. J Neurosci. 24(41): 9027-9034. 
Joo, W., Hippenmeyer, S., Luo, L. (2014). Neurodevelopment: Dendrite morphogenesis depends 
on relative levels of NT-3/TrkC signaling. Science. 346(6209): 626-629. 
Juriloff, D. M. and Harris, M. J. (2000). Mouse models for neural tube closure defects. Hum Mol 
Genet. 9(6): 993-1000. 
Kahr, I., Vandepoele, K., and van Roy, F. (2013). Delta-Protocadherins in Health and Disease. 
Prog Mol Biol Transl Sci. 116: 169-192. 
Kappen, C. (2013). Modeling Anterior Development in Mice: Diet as Modulator of Risk for 
Neural Tube Defects. Am J Med Genet C Semin Med Genet. 0(4): 333-356. 
Kikuchi, A. (1999). Roles of Axin in the Wnt Signaling Pathway. Cell. Signal. 11(11): 777-788. 
Kim, S., Yasuda, S., Tanaka, H., Yamagata, K., and Kim, H. (2011). Non-clustered 
protocadherin. Cell Adh Migr. 5(2): 97-105. 
Krishna, K., Hertel, N., and Redies, C. (2011). Cadherin expression in the somatosensory cortex: 
evidence for a combinatorial molecular code at the single-cell level. Neurosci. 175(17): 
37-48. 
Kubota, F., Murakami, T., Tajika, Y, and Yorifuji, H. (2008). Expression of protocadherin 18 in 
the CNS and pharyngeal arches of zebrafish embryos. Int. J. Dev. Biol. 52: 397-405. 
Kwong, A. K., Fung, C., Chan, S., and Wong, V. C. (2012). Identification of SCN1A and 
PCDH19 Mutations in Chinese Children with Dravet Syndrome. PLoS One. 7(7). 
Leonardi, E., Sartori, S., Vecchi, M., Bettella, E., Polli, R., De Palma, L., Boniver, C., and 
Murgia, A. (2014). Identification of four novel PCDH19 mutations and prediction of their 
functional impact. Annals of Human Genetics. 78(6): 389-398. 
34 
 
Liu, Q., Chen, Y., Kubota, F., Pan, J. J., and Murakami, T. (2010). Expression of protocadherin-
19 in the nervous system of the embryonic zebrafish. Int. J. Dev. Biol. 54: 905-911. 
Liu, Q., Chen, Y., Pan, J. J., and Murakami, T. (2009). Expression of protocadherin-9 and 
protocadherin-17 in the nervous system of the embryonic zebrafish. Gene Expr Patterns. 
9(7): 490-496. 
Lu, W., Yamamoto, V., Ortega, B., Baltimore, D. (2004). Mammalian Ryk Is a Wnt Coreceptor 
Required for Stimulation of Neurite Outgrowth. Cell. 119(1): 97-108. 
Lyu, J., Yamamoto, V., Lu, W. (2008). Cleavage of the Wnt Receptor Ryk Regulates Neuronal 
Differentiation during Cortical Neurogenesis. Dev Cell. 15(5): 773-780. 
MacDonald, B. T., Tamai, K., He, X. (2009). Wnt/β-Catenin Signaling: Components, 
Mechanisms, and Diseases. Dev Cell. 17(1): 9-26.  
Malinverno, M., Carta, M., Epis, R., Marcello, E., Verpelli, C., Cattabeni, F., Sala, C., Mulle, C., 
Di Luca, M., and Gardoni, F. (2010). J Neurosci. 30(48): 16343-16355. 
Marambaud, P., Wen, P. H., Dutt, A., Shioi, J., Takashima, A., Siman, R., and Robakis, N. K. 
(2003). A CBP Binding Transcriptional Repressor Produced by the PS1/ϵ-Cleavage of N-
Cadherin Is Inhibited by PS1 FAD Mutations. Cell. 114(5): 635-645.  
Marini, C., Darra, F., Specchio, N., Mei, D., Terracciano, A., Parmeggiani, L., Ferrari, A., Sicca, 
F., Mastangelo, M., Spaccini, L., Canopoli, M. L., Cesaroni, E., Zamponi, N., Caffi, L., 
Ricciardelli, P., Grosso, S., Pisano, T., Canevini, M. P., Granata, T., Accorsi, P., 
Battaglia, D., Cusmai, R., Vigavano, F., Bernardina, B. D. Guerrini, R. (2012). Focal 
seizures with affective symptoms are a major feature of PCDH19 gene-related epilepsy. 
Epilepsia. 53(12): 2111-2119. 
Marini, C., Mei, D., Parmeggiai, L., Norci, V., Calado, E., Ferrari, A., Moreira, A., Pisano, T., 
Specchio, N., Vigevano, F., Battaglia, D., and Guerrini, R. (2010). Protocadherin 19 
mutations in girls with infantile-onset epilepsy. 
Miyamoto, Y., Sakane, F., and Hashimoto, K. (2015). N-cadherin-based adherens junction 
regulates the maintenance, proliferation, and differentiation of neural progenitor cells 
during development. Cell Adh Migr. 9(3): 183-192. 
Nadarajah, B., Brunstrom, J. E., Grutzendler, J., Wong, R. O., and Pearlman, A. L. (2001). Two 
modes of radial migration in early development of the cerebral cortex. Nat Neurosci. 
4(2): 143-150.  
Noles, S. R. and Chenn, A. (2007). Cadherin inhibition of beta-catenin signaling regulates the 
proliferation and differentiation of neural precursor cells. Mol Cell Neurosci. 35(4): 549-
558. 
Panula, P., Chen, Y. C., Priyadarshini, M., Kudo, H., Semenova, S., Sundvik, M., and Sallinen, 
V. (2010). Neurobiology of Disease. 40(1): 46-57. 
Redies, C., Hertel, N., and Hubner, C. A. (2012). Cadherins and neuropsychiatric disorders. 
Brain Research. 1470(27): 130-144. 
Redies, C., Neudert, F., and Lin, J. (2011). Cadherins in Cerebellar Development: Translation of 
Embryonic Patterning into Mature Functional Compartmentalization. Cerebellum. 10(3): 
393-408. 
Redies, C., Vanhalst, K., and van Roy, F. (2005). δ-Protocadherins: unique structures and 
function. Cell Mol Life Sci. 62(23): 2840-2852.  
Reiss, K., Maretzky, T., Ludwig, A., Tousseyn, T., de Strooper, B., Hartmann, D., and Saftig, P. 
(2005). ADAM10 cleavage of N-cadherin and regulation of cell–cell adhesion and β-
catenin nuclear signaling. EMBO J. 24(4): 742-752. 
35 
 
Rinkwitz, S., Mourrain, P., and Becker, T. S. (2010). Zebrafish: an integrative system for 
neurogenomics and neurosciences. Progress in Neurobiology. 93(2): 231-243. 
Saftig, P., and Lichtenthaler, S. F. (2015). The alpha secretase ADAM10: A metalloprotease with 
multiple functions in the brain. Progress in Neurobiology. 135: 1-20. 
Scheffer, I. E. (2012). Diagnosis and long term course of Dravet Syndrome. Eur J Paediatr 
Neurol. 16(S1): S5-S8. 
Scheffer, I. E., Turner, S. J., Dibbens, L. M., Bayly, M. A., Friend, K., Hodgson, B., Burrows, L., 
Shaw, M., Wei, C., Ullmann, R., Ropers, H. H., Szepetowski, P., Haan, E., Mazarib, A., 
Afawi, Z., Neufeld, M. Y., Andrews, P. I., Wallace, G., Kivity, S., Lev, D., Lerman-
Sagie, T., Derry, C. P., Korczyn, A. D., Gecz, J., Mulley, J. C., Berkovic, S. F. (2008). 
Epilepsy and mental retardation limited to females: an under-recognized disorder. Brain. 
131(4): 918-927. 
Sinevas, G. S., and Pospelov, V. A. (2014). β-Catenin in pluripotency: adhering to self-renewal 
or Wnting to differentiate? Int Rev Cell Mol Biol. 312: 53-78. 
Specchio, N., Marini, C., Terracciano, A., Mei, D., Trivisano, M., Sicca, F., Fusco, L., Cusmai, 
R., Darra, F., Bernardina, B. D., Bertini, E., Guerrini, R., and Vigevano, F. (2011). 
Spectrum of phenotypes in female patients with epilepsy due to protocadherin 19 
mutations. Epilepsia. 52(7): 1251-1257. 
Stevenson, R. E., Holden, K. R., Rogers, R. C., Schwartz, C. E. (2012). Seizures and X-linked 
intellectual disability. Eur J Med Genet. 55(5): 307-12. 
Sumbre, G. and de Polavieja, G. G. (Eds.). (2014). The World According to Zebrafish: How 
Neural Circuits Generate Behaviour. Lausanne, Switzerland: Frontiers Media SA. 
Terracciano, A., Trivisano, M., Cusmai, R., De Palma, L., Fusco, L., Compagnucci, C., Bertini, 
E., Vigevano, F., Specchio, N. (2016) PCDH19-related epilepsy in two mosaic male 
patients. Epilepsia. 57(3): 51-55. 
Tourette, C., Farina, F., Vazquez-Manrique, R. P., Orfila, A. M., Voisin, J., Hernandez, S., 
Offner, N., Parker, J. A., Menet, S., Kim, J., Lyu, J., Choi, S. H. Cormier, K., Edgerly, C. 
K., Bordiuk, O. L., Smith, K., Louise, A., Halford, M., Stacker, S., Vert, J. P., Ferrante, 
R. J., Lu, W., Neri, C. (2014). The Wnt receptor Ryk reduces neuronal and cell survival 
capacity by repressing FOXO activity during the early phases of mutant huntingtin 
pathogenicity. PLoS Biol. 12(6). 
Uemura, K., Kihara, T., Kuzuya, A., Okawa, K., Nishimoto, T., Ninomiya, H., Sugimoto, H., 
Kinoshita, A., and Shimohama, S. (2006). Characterization of sequentical N-cadherin 
cleavage by ADAM10 and PS1. Neuroscience Letters. 402(3): 278-283. 
Vanhalst, K., Kools, P., Staes, K., van Roy, F., and Redies, C. (2005). δ-Protocadherins: a gene 
family expressed differentially in the mouse brain. Cell Mol Life Sci. 62(11): 1247-1259.  
Weiner, J. A., and Jontes, J. D. (2013). Protocadherins, not prototypical: a complex tale of their 
interactions, expression, and functions. Front Mol Neurosci. 6(4).  
Westerfield, M. (1995) The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio 
rerio), 3rd Edition. Eugene, OR, University of Oregon Press. 
Wrobel, C. N., Mutch, C. A., Swaminathan, S., Taketo, M. M., Chenn, A. (2007). Persistent 
expression of stabilized β-catenin delays maturation of radial glial cells into intermediate 
progenitors. Dev Biol. 309(2): 285-297.  
Wu, H., Luo, J., Yu, H., Rattner, A., Mo, A., Wang, Y., Smallwood, P. M., Erlanger, B., 
Wheelan, S. J., and Nathans, J. (2014). Cellular resolution maps of X-chromosome 
36 
 
inactivation: implications for neural development, function, and disease. Neuron. 81(1): 
103-119. 
Zhang, J., Shemezis, J. R., McQuinn, E. R., Wang, J., Sverdlov, M., and Chenn, A. (2013). AKT 
activation by N-cadherin regulates beta-catenin signaling and neuronal differentiation 
during cortical development. Neural Dev. 8(7). 
Zhang, J., Woodhead, G. J., Swaminathan, S. K., Noles, S. R., McQuin, E. R., Pisarek, A. J., 
Stocker, A. M., Mutch, C. A., Funatsu, N., and Chenn, A. (2010). Cortical neural 
precursors inhibit their own differentiation via N-cadherin maintenance of beta-catenin 
signaling. Dev Cell. 18(3): 472-479. 
Zhong, W. (2008). Going nuclear is again a winning (Wnt) strategy. Dev Cell. 15(5): 635-636. 
 
